Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/14/2000US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase
11/14/2000US6146847 Stabilized transient gene expression
11/14/2000US6146846 Primosome protein a of streptococcus pneumoniae
11/14/2000US6146837 Detecting fc gamma receptor (cd64) in a biological sample by conacting sample with cyanin compound, cy5; illuminating the sample with light of an appropriate excitation wavelength; and detecting fluorescence
11/14/2000US6146835 Nucleotide sequence; for drug screening of novel analgesics; for recombinant production of receptor
11/14/2000US6146829 Gapped 2' modified oligonucleotides
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146664 Stable topical ascorbic acid compositions
11/14/2000US6146662 Dosage form of calcium channel blocker drug, and a polymer of given molecular weight and rate of hydration that changes the form from non-dispensable phase to a dispensable phase; and a drug-delayed delivery composition comprising a polymer
11/14/2000US6146659 Method of administering liposomal encapsulated taxane
11/14/2000US6146658 Prodrugs, their preparation and use as pharmaceuticals
11/14/2000US6146653 Pharmaceutical preparation and a method for the treatment of diabetes
11/14/2000US6146636 Substance P antagonists comprising rosaceae plant extracts
11/14/2000US6146616 Antioxidant and/or antielastase composition based on lupine oil
11/14/2000CA2308826A1 Combination therapy for the treatment of migraine
11/14/2000CA2308824A1 Combination therapy for the treatment of migraine
11/14/2000CA2308323A1 5ht1 receptor agonists and either a cox-2 inhibitor or nsaid for the treatment of migraine
11/14/2000CA2271965A1 Method of producing betulinic acid
11/14/2000CA2188933C Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/14/2000CA2178277C Method for preventing heartburn
11/14/2000CA2153775C Potentiation of temozolomide in human tumour cells
11/14/2000CA2105912C Nadh and nadph as drugs for treating alzheimer's disease
11/14/2000CA2103458C Method and composition to reduce myocardial reperfusion injury
11/14/2000CA2080221C An improved process for the preparation of substituted indolone derivatives
11/14/2000CA2050284C Pcp receptor ligands and the use thereof
11/14/2000CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives
11/14/2000CA2000763C Dispersable formulation
11/14/2000CA1341139C Tetrahydropyridine oxime cholinergic agents and method of treatment
11/12/2000CA2721484A1 Dopamine transporter imaging agents
11/10/2000CA2307958A1 Patch and method for transdermal delivery of bupropion base
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000067024A1 Cancer treatment with endothelin receptor antagonists
11/09/2000WO2000067016A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066764A1 Methods for increasing t cell proliferation
11/09/2000WO2000066752A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066665A1 Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same
11/09/2000WO2000066635A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules
11/09/2000WO2000066632A1 Agonists or antagonists for haemopoietic growth factors
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066617A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000WO2000066614A1 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY
11/09/2000WO2000066612A1 Androgen glycosides and androgenic activity thereof
11/09/2000WO2000066611A1 Steroid derivatives
11/09/2000WO2000066608A1 Tumor necrosis factor-gamma
11/09/2000WO2000066604A2 L-ribo-lna analogues
11/09/2000WO2000066603A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000WO2000066602A1 3-deoxy-desmycosin derivatives and process for their preparation
11/09/2000WO2000066601A1 Method for preparing aloin by extraction
11/09/2000WO2000066595A1 Heterocyclic carboxylic acid derivatives
11/09/2000WO2000066593A2 Novel spirocyclic compounds, method for the production thereof and their use for treating hyperproliferative diseases
11/09/2000WO2000066591A1 Cyclocarbamate and cyclic amide derivatives
11/09/2000WO2000066589A1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066586A1 Heteroaryl diazabicycloalkanes, their preparation and use
11/09/2000WO2000066585A1 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
11/09/2000WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
11/09/2000WO2000066583A1 Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
11/09/2000WO2000066582A1 Substituted pyrazole derivative
11/09/2000WO2000066581A1 Cyanopyrroles as progesterone receptor agonists
11/09/2000WO2000066580A2 Antifungal ethers
11/09/2000WO2000066577A2 Brigded cycloalkanes as thromboxane ligands without blood clotting effects
11/09/2000WO2000066576A1 Isoflavone metabolites
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066571A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000WO2000066570A1 Cyclothiocarbamate derivatives as progesterone receptor modulators
11/09/2000WO2000066567A1 Pyrimidinone compounds
11/09/2000WO2000066566A1 Pyrimidine compounds
11/09/2000WO2000066564A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/09/2000WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066557A1 New compounds
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066555A1 Thio-oxindole derivatives
11/09/2000WO2000066553A1 Substituted indole sulfonamides as antiviral agents
11/09/2000WO2000066550A1 New compounds
11/09/2000WO2000066546A2 Monofluoroalkyl derivatives
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066225A1 Contraceptive compositions containing cyclic carbamates and amide derivatives
11/09/2000WO2000066183A1 Vascular embolic materials having multifunctions
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000066174A2 Compounds
11/09/2000WO2000066173A2 Targeting of infectious agents bearing host cell proteins
11/09/2000WO2000066172A1 Non-aqueous liquid shampoo composition
11/09/2000WO2000066170A1 Prucalopride oral solution
11/09/2000WO2000066169A1 Pharmaceutical formulations
11/09/2000WO2000066168A1 Compositions containing benzimidazolones and progestogens
11/09/2000WO2000066167A1 Contraceptive compositions containing indoline derivatives and progestational agents
11/09/2000WO2000066166A1 Contraceptive compositions containing 3,3-substituted indoline derivatives and uses thereof
11/09/2000WO2000066165A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
11/09/2000WO2000066164A1 Contraceptive compositions containing antiprogestinic and progestinic
11/09/2000WO2000066163A1 Contraceptive compositions containing 2,1-benzisothiazoline 2,2-dioxides and progestationals
11/09/2000WO2000066161A1 Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
1 ... 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 ... 7860